Carbamazepine and DOAC — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Carbamazepine can reduce apixaban exposure and anticoagulant effect
Carbamazepine is a strong enzyme inducer and can reduce exposure to some DOACs, risking thrombosis. Anticoagulant choice should be reviewed by the prescriber. This is clinically important because the drug is used to prevent stroke in AF.
Reference: BNF